Trinity Biotech (NASDAQ:TRIB) reported $19.52 million in sales this quarter. This is a 40.41 percent decrease over sales of $32.77 million the same period last year.
Piper Sandler Downgrades Varonis Systems to Neutral, Lowers Price Target to $20
Piper Sandler analyst Rob Owens downgrades Varonis Systems (NASDAQ:VRNS) from Overweight to Neutral and lowers the price target from $37 to $20.